Searchable abstracts of presentations at key conferences in endocrinology

ea0056gp155 | Obesity | ECE2018

Changes in gut microbiota and metabolic profiles after sleeve gastrectomy

Puig Rocio , Pellitero Silvia , Martinez Eva , Tarasco Jordi , Moreno Pau , Vilarrasa Nuria , Vendrell Joan , Fernandez Sonia , Puig-Domingo Manel

We aimed to assess the effect of sleeve gastrectomy (SG) on the metabolic and gut microbiota profiles in non-diabetic obese patients with different grade of insulin resistance (IR).Methods: Prospective study of 22 morbid non-diabetic obese patients (77.2% women, age 47.13±9.51 years, basal BMI 45.59±4.99 kg/m2, 11 IR and 11 non-IR) undergoing SG. A fasting blood sample was collected at baseline and at 6 months post-SG for the determi...

ea0056gp116 | Diabetes Translational | ECE2018

The role of oncostatin m in the development of type 2 diabetes associated with obesity

Taxeras Siri , Piquer-Garcia Irene , Pellitero Silvia , Puig Rocio , Martinez Eva , Tarasco Jordi , Moreno Pau , Bombuy Ernest , Higueras Carmen , Malagon Paloma , Lerin Carles , Puig-Domingo Manel , Sanchez-Infantes David

Background: Obesity can lead type 2 diabetes (T2D), however there are patients with obesity who present euglycemia. The mechanisms by which T2D appears have not been fully elucidated. Oncostatin m (OSM) is a proinflammatory cytokine, member of the IL-6 family, which is increased in obesity in mice and humans, and impairs browning in mice. Here, we aim at evaluating the potential role of OSM in the development of T2D in patients with obesity.Material and ...